Search

Your search keyword '"Kimby, Eva"' showing total 398 results

Search Constraints

Start Over You searched for: Author "Kimby, Eva" Remove constraint Author: "Kimby, Eva" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
398 results on '"Kimby, Eva"'

Search Results

1. Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma

2. Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma

3. Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials

4. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

7. Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials

10. Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

13. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

16. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

17. Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

18. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial

21. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

22. Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

23. Lack of reproducibility of histopathological features in MYC‐rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium.

24. Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia.

25. Health-related quality of life and chronic fatigue in long-term survivors of indolent lymphoma – a comparison with normative data.

32. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

39. ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

40. Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop

41. Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non‐Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study.

42. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur

49. Multi-Omics Profiling of Longitudinal Samples Reveals Early Genomic Changes in Follicular Lymphoma

Catalog

Books, media, physical & digital resources